Header Logo

Connection

IRINA AGOULNIK to Cell Proliferation

Back to Details
This is a "connection" page, showing publications IRINA AGOULNIK has written about Cell Proliferation.
IRINA AGOULNIK
Connection Strength
0.869
Cell Proliferation
  1. Inhibition of base excision repair by natamycin suppresses prostate cancer cell proliferation. Biochimie. 2020 Jan; 168:241-250.
    View in: PubMed
    Score: 0.368
  2. Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells. Sci Rep. 2020 03 02; 10(1):3836.
    View in: PubMed
    Score: 0.094
  3. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis. FASEB J. 2019 11; 33(11):12435-12446.
    View in: PubMed
    Score: 0.090
  4. INPP4B suppresses prostate cancer cell invasion. Cell Commun Signal. 2014 Sep 25; 12:61.
    View in: PubMed
    Score: 0.064
  5. Androgen receptor footprint on the way to prostate cancer progression. World J Urol. 2012 Jun; 30(3):279-85.
    View in: PubMed
    Score: 0.052
  6. Coactivator selective regulation of androgen receptor activity. Steroids. 2009 Aug; 74(8):669-74.
    View in: PubMed
    Score: 0.044
  7. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res. 2006 Nov 01; 66(21):10594-602.
    View in: PubMed
    Score: 0.037
  8. Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem. 2006 Oct 01; 99(2):362-72.
    View in: PubMed
    Score: 0.037
  9. INPP4B is an oncogenic regulator in human colon cancer. Oncogene. 2016 06 09; 35(23):3049-61.
    View in: PubMed
    Score: 0.017
  10. Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells. Int J Biochem Cell Biol. 2013 Apr; 45(4):763-72.
    View in: PubMed
    Score: 0.014
  11. Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis. Endocr Relat Cancer. 2010 Dec; 17(4):1021-33.
    View in: PubMed
    Score: 0.012
  12. Relaxin/RXFP1 signaling in prostate cancer progression. Ann N Y Acad Sci. 2009 Apr; 1160:379-80.
    View in: PubMed
    Score: 0.011
  13. Developmental expression and gene regulation of insulin-like 3 receptor RXFP2 in mouse male reproductive organs. Biol Reprod. 2007 Oct; 77(4):671-80.
    View in: PubMed
    Score: 0.010
  14. Relaxin promotes prostate cancer progression. Clin Cancer Res. 2007 Mar 15; 13(6):1695-702.
    View in: PubMed
    Score: 0.010
  15. The role of relaxin in endometrial cancer. Cancer Biol Ther. 2006 Jan; 5(1):71-7.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.